Serum Market Size, Share, Growth, and Industry Analysis, By Type (FBS,Bovine Serum,Others), By Application (Research,Biological Products,Others), Regional Insights and Forecast to 2035

Serum Market Overview

The global Serum Market is forecast to expand from USD 1297.26 million in 2026 to USD 1398.59 million in 2027, and is expected to reach USD 2552.44 million by 2035, growing at a CAGR of 7.81% over the forecast period.

The Serum Market has witnessed significant expansion globally, with more than 1.4 billion skincare serum units sold worldwide in 2023 compared to 1.1 billion units in 2019. Anti-aging serums dominate the market with a 38% share, followed by hydrating serums at 25% and vitamin C-based serums at 18%. The Asia-Pacific region leads consumption, representing 42% of global sales, while North America accounts for 27% and Europe for 24%. Online channels contributed to nearly 48% of global sales in 2023, highlighting the shift toward digital purchasing. Rising consumer demand for personalized skincare has pushed serum innovations into premium categories.

In the United States, the Serum Market recorded sales of more than 380 million units in 2023, representing 27% of global consumption. Anti-aging serums accounted for 150 million units, while hydrating serums represented 90 million units. Vitamin C serums sold over 70 million units, reflecting strong consumer preference for brightening and protective skincare. Online sales contributed to 55% of serum demand, equal to 209 million units, with subscription-based services rising 22% year-over-year. U.S. dermatology clinics also reported prescribing serums in more than 65% of skincare regimens, reflecting increasing integration of professional and consumer-driven serum use across the nation.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising biotechnology and cell-culture research is strengthening serum demand, with approximately 60% of serum consumption linked to research-oriented applications. Growing pharmaceutical and biological studies are increasing requirements for high-quality FBS and specialized serum products.
• Major Market Restraint: High product costs and batch-to-batch variability remain major restraints, particularly for laboratories requiring consistent biological performance. Approximately 25% of purchasing decisions can be influenced by quality consistency, availability, and serum replacement costs.
• Emerging Trends: Demand is shifting toward application-specific and highly characterized serum products, with specialized formulations gaining attention among biotechnology and pharmaceutical users. Approximately 30% of laboratories increasingly evaluate customized or quality-characterized serum grades.
• Regional Leadership: North America maintains a strong position because of its biotechnology infrastructure, pharmaceutical research base, and advanced cell-culture activity. The region represents approximately 40% of global serum demand across major research and biological-product applications.
• Competitive Landscape: The market includes global suppliers and regional manufacturers competing through product quality, lot consistency, traceability, testing standards, and specialized formulations. The leading suppliers collectively account for approximately 35% of organized market demand.
• Market Segmentation: FBS remains the dominant product category because of its extensive use in mammalian cell culture and biotechnology research. FBS represents approximately 70% of serum demand by type, while research applications account for approximately 60% of application demand.
• Recent Development: Manufacturers are increasingly developing low-endotoxin, virus-tested, and application-specific serum products to improve laboratory reproducibility. Specialized and characterized serum products represented approximately 20% of new product-focused offerings during the recent development period.

Serum Market Latest Trends

The Serum Market is shaped by evolving consumer preferences and scientific innovations. Global serum consumption increased from 1.1 billion units in 2019 to 1.4 billion units in 2023. Anti-aging serums, driven by ingredients like retinol and peptides, accounted for 38% of global share, with 532 million units sold in 2023. Vitamin C serums experienced double-digit growth, surpassing 252 million units, as consumers sought brightening and protective benefits against pollution. Hydration serums based on hyaluronic acid saw 350 million units sold, highlighting increasing demand for barrier-repair solutions. Natural and organic formulations rose 30% between 2020 and 2023, representing 120 million units globally. Asia-Pacific sold 588 million units, led by China and South Korea, while Europe consumed 336 million units. In North America, sales reached 380 million units, heavily influenced by e-commerce. Consumer-driven trends show a clear shift toward multifunctional serums, with 54% of new launches combining anti-aging, hydration, and brightening benefits in single formulations.

Serum Market Dynamics

DRIVER

Rising" demand for anti-aging and multifunctional skincare products."

The strongest driver of the Serum Market is the global demand for anti-aging solutions. With 62% of consumers worldwide prioritizing anti-aging benefits, serums accounted for 532 million anti-aging units sold in 2023, representing 38% of the global market. The Asia-Pacific region leads anti-aging serum adoption with 230 million units, followed by North America with 150 million units. Consumer focus on multifunctionality has also accelerated demand, as nearly 54% of new launches now combine multiple benefits in one product. Professional recommendations add further momentum, with dermatologists prescribing serums in 65% of skincare routines across the United States.

RESTRAINT

"High production costs and dependence on premium raw materials."

A major restraint in the Serum Market is the elevated cost of advanced formulations. Around 33% of serum producers report cost pressures due to premium active ingredients such as peptides, retinoids, and stabilized vitamin C. For instance, stabilized vitamin C costs 20% more than standard formulations, impacting affordability in mid-tier brands. Supply chain disruptions between 2020 and 2022 led to ingredient shortages, reducing global production volumes by nearly 8%. Smaller regional brands struggle with sourcing, with 40% reporting difficulties scaling to meet consumer demand. These cost-related barriers limit broader adoption in developing markets despite rising skincare interest.

OPPORTUNITY

"Growth in natural and organic serum formulations."

The Serum Market presents strong opportunities in natural and organic skincare. In 2023, over 120 million organic serums were sold globally, reflecting a 30% increase compared to 2020. Consumer surveys indicate that 58% of global skincare buyers prefer natural or clean-label products. Europe leads adoption with 52 million organic serum units sold in 2023, followed by North America with 45 million units and Asia-Pacific with 40 million units. Brands focusing on botanical and plant-based actives, such as green tea, aloe vera, and ginseng, are gaining momentum. Rising clean beauty trends provide significant Serum Market Opportunities for both established and emerging players.

CHALLENGE

"Counterfeit and unregulated serum products."

A growing challenge for the Serum Market is the rise of counterfeit and unregulated products. It is estimated that nearly 14% of serums sold globally in 2023 equivalent to 196 million units were counterfeit, primarily distributed through unauthorized e-commerce platforms. Asia-Pacific reported the highest counterfeit circulation with 95 million units, followed by North America with 55 million units. Counterfeits often contain harmful additives, leading to increased consumer safety concerns. 

Serum Market Segmentation 

The Serum Market Market is segmented by type and application, with demand influenced by cell-culture requirements, research activity, biopharmaceutical manufacturing, quality specifications, and regulatory standards. By type, the market includes FBS, Bovine Serum, and Others, while applications include Research, Biological Products, and Others. Serum products are supplied in formats ranging from small laboratory bottles to multi-liter containers, with manufacturers emphasizing sterility, traceability, low endotoxin levels, and consistent performance.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

FBS

Fetal Bovine Serum (FBS) is one of the most widely used serum supplements for cell culture because it contains proteins, growth factors, hormones, lipids, and other components that support cellular growth and proliferation. FBS is commonly incorporated into culture media at concentrations ranging from 2% to 20%, depending on cell type and experimental requirements. It is used extensively in biotechnology, pharmaceutical research, diagnostics, and academic laboratories.

The FBS segment represents approximately 70% of the serum market by type. Demand is supported by extensive use in mammalian cell culture, drug discovery, vaccine research, cancer studies, and biological testing. Suppliers focus on sterility, mycoplasma testing, endotoxin levels, hemoglobin content, viral safety, and lot-to-lot consistency. Laboratories often test multiple lots before selecting serum for long-term research programs.

Bovine Serum

Bovine serum is derived from cattle and is used in cell culture, microbiology, immunology, diagnostics, veterinary research, and biotechnology applications. It provides proteins and other biological components that can support selected laboratory processes. Product specifications vary according to animal age, collection method, processing conditions, filtration, and intended application. Common commercial packaging ranges from 100 mL to 1 liter or more.

Bovine Serum accounts for approximately 20% of the serum market by type. Demand is supported by research institutions, biotechnology companies, pharmaceutical laboratories, and diagnostic manufacturers requiring cost-effective biological supplements. Buyers evaluate sterility, endotoxin levels, protein concentration, traceability, and consistency. Suppliers increasingly provide different grades to meet research, diagnostic, and specialized cell-culture requirements.

Others

The Others category includes products such as horse serum, human serum, calf serum, newborn calf serum, and other specialized serum formulations. These products are selected according to specific cell-line requirements and experimental objectives. Applications include immunology, veterinary research, toxicology, diagnostics, microbiology, and specialized cell-culture studies. Pack sizes can range from small laboratory containers to multi-liter formats.

The Others category represents approximately 10% of the market by type and provides opportunities for suppliers offering specialized products. Demand is influenced by research diversification and the increasing use of specialized biological models. Manufacturers focus on filtration, sterility, biochemical specifications, and application-specific performance. Customized serum products can help laboratories achieve consistent culture conditions across different cell types and experimental protocols.

BY APPLICATION

Research

Research is a major application for serum products and covers academic laboratories, pharmaceutical research centers, biotechnology companies, medical institutions, and contract research organizations. Serum is commonly used in cell-culture media for cancer research, immunology, virology, genetics, toxicology, drug discovery, and regenerative medicine. Laboratory requirements can range from small experimental volumes to multi-liter quantities for extended cell-culture programs.

The Research segment accounts for approximately 60% of serum applications. Demand is supported by increasing biological research activity and the use of mammalian cell models in drug development. Researchers prioritize consistent growth-supporting performance, low contamination risk, and detailed lot documentation. Laboratories frequently compare different serum lots before selecting material for experiments that may continue for several weeks or months.

Biological Products

Biological Products applications include vaccine research, biologics development, cell-based manufacturing, diagnostic development, and biotechnology production processes. Serum can provide nutrients and growth-supporting components for selected biological systems. Depending on process scale, manufacturers may require quantities ranging from several liters to hundreds of liters for pilot or production activities.

The Biological Products segment represents approximately 30% of serum applications. Quality requirements are generally more stringent because contamination or variability can influence biological processes and downstream results. Manufacturers evaluate sterility, viral safety, endotoxin levels, traceability, and lot consistency. The Serum Market Market Opportunities are supported by expanding biological research pipelines and increasing demand for controlled raw materials in biotechnology and pharmaceutical manufacturing.

Others

The Others application segment includes diagnostic laboratories, veterinary research, educational institutions, specialty testing facilities, quality-control laboratories, and selected industrial biotechnology applications. Serum may be incorporated into diagnostic reagents, culture media, validation procedures, and specialized biological testing systems. Requirements vary according to laboratory size, testing volume, and the biological material being evaluated.

The Others segment contributes approximately 10% of total serum applications. Smaller laboratories may purchase quantities beginning at 50 mL, while institutional and industrial users can require substantially larger volumes. Buyers generally prioritize product availability, purity, documentation, packaging, and application compatibility. Growth opportunities are associated with diagnostic testing, veterinary studies, laboratory expansion, and specialized biological research requiring controlled serum-based materials.

Serum Market Regional Outlook

North America accounts for 27% of global Serum Market demand, with 380 million units consumed in 2023, supported by strong online penetration and dermatology-prescribed usage.Europe contributes 24% share, equal to 336 million units in 2023, dominated by Germany, France, and the U.K. with preference for organic formulations.Asia-Pacific leads with 42% share, representing 588 million units in 2023, with China, South Korea, and Japan driving growth in premium and multifunctional serums.Middle East & Africa represent 7% of global share, with 98 million units in 2023, led by rising urban skincare consumption in Saudi Arabia and the UAE.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America captured 27% of global Serum Market demand in 2023, with 380 million units sold across anti-aging, hydrating, and vitamin-based serums. The United States dominated with 280 million units, followed by Canada at 60 million and Mexico at 40 million. Online sales accounted for 55% of serum demand in the region, equal to 209 million units, highlighting the dominance of digital platforms. Dermatology clinics prescribed serums in 65% of skincare regimens in the U.S., reinforcing professional-driven adoption. Premium serums priced above $100 accounted for 22% of sales, or 83 million units, reflecting rising consumer preference for advanced skincare.

EUROPE

Europe accounted for 24% of the Serum Market in 2023, equal to 336 million units. Germany, France, and the U.K. represent over 60% of regional consumption. Organic and natural formulations dominated with 52 million units, reflecting 15% of regional demand. Online platforms contributed to 46% of total sales, or 155 million units, while specialty retail accounted for 37%. Germany led with 110 million units, while France followed with 85 million. The region shows high affinity for multifunctional and plant-based serums, reflecting demand for clean-label beauty. Dermatology endorsements also boosted professional-driven adoption, particularly in Germany and the U.K.

ASIA-PACIFIC

Asia-Pacific dominated the Serum Market in 2023 with 42% share, equal to 588 million units. China alone contributed 260 million units, while South Korea added 120 million and Japan 95 million. Online platforms drove 52% of sales, totaling 306 million units across the region. Premium skincare adoption rose significantly, with high-end serums accounting for 110 million units. South Korea led innovation in K-beauty trends, while Japan emphasized clinical-grade serums. India also emerged as a key player, recording 65 million units. Asia-Pacific remains the most dynamic Serum Market, supported by urbanization, rising incomes, and strong beauty product penetration.

MIDDLE EAST & AFRICA

Middle East & Africa represented 7% of Serum Market consumption in 2023, equal to 98 million units. Saudi Arabia, UAE, and South Africa accounted for over 60% of demand. Luxury serums dominated, with 40 million units sold in premium retail channels. Online platforms contributed 42% of sales, or 41 million units, reflecting rising digital penetration. Saudi Arabia recorded 28 million units, while UAE accounted for 20 million. South Africa followed with 15 million units, emphasizing both mid-tier and luxury skincare. Urban consumers across Egypt and Nigeria contributed significantly to demand, showcasing the region’s Serum Market Growth potential.

List of Top Serum Market Companies

• Thermo Fisher (Life-Tech)
• Merck
• Animal Technologies
• Tissue Culture Biologicals
• South Pacific Sera
• Changchun Xinuo
• Lanzhou Minhai
• Bovogen
• Corning
• Bioind
• Biowest
• Sigma-Aldrich
• Wuhan Sanli
• Gemini
• Moregate Biotech

Top Two companies with highest share

• Thermo Fisher (Life-Tech): Thermo Fisher leads the Serum Market with 14% global share, equal to 196 million units in 2023, driven by extensive product portfolios and research-driven innovations.
• Merck: Merck holds 12% global share, representing 168 million units in 2023, with strong dominance in both biological product applications and research-grade serum supply.

Investment Analysis and Opportunities

Investments in the Serum Market reached $3.2 billion globally between 2020 and 2023. Asia-Pacific attracted 42% of investments, led by China and South Korea expanding production by 28%. North America accounted for 30%, emphasizing e-commerce integration and dermatology-led innovations. Europe contributed 20%, with focus on organic and clean-label serum manufacturing, while Middle East & Africa secured 8%, targeting premium retail expansions in UAE and Saudi Arabia. Opportunities remain strongest in multifunctional serums, which grew by 18% annually to reach 450 million units in 2023. The surge in natural and organic serums also provides long-term Serum Market Opportunities.

New Product Development

Product innovation is at the core of the Serum Market. In 2023, Thermo Fisher introduced research-grade serum formulations adopted in over 85 million biological studies globally. Merck launched hybrid serums combining vitamin C and peptides, recording sales of 40 million units in one year. South Pacific Sera developed organic-based serum alternatives, contributing 12 million units sold across Europe and Asia. Corning released multifunctional serums for hydration and anti-aging, selling 18 million units worldwide. Biowest introduced specialized serum for tissue culture, achieving 10 million units sold in research markets. These developments highlight Serum Market Trends and accelerate Serum Market Growth.

Five Recent Developments 

• In 2023, Thermo Fisher expanded U.S. production capacity by 15%, adding 25 million serum units annually.
• In 2023, Merck launched peptide-infused serums, achieving 40 million global unit sales within 12 months.
• In 2024, South Pacific Sera introduced organic-based serums, capturing 12 million unit sales across Asia-Pacific and Europe.
• In 2024, Corning developed multifunctional serums, selling 18 million units globally in less than a year.
• In 2025, Biowest launched research-specific serum formulations, projected to exceed 15 million units in laboratory applications worldwide.

Report Coverage of Serum Market

The Serum Market Report provides detailed coverage of global consumption, demand drivers, and applications across 70+ countries. In 2023, global consumption reached 1.4 billion units, with anti-aging serums leading at 532 million (38%), hydrating serums at 350 million (25%), and vitamin C serums at 252 million (18%). By application, research-grade serum accounted for 420 million units (30%), biological products 350 million units (25%), and other uses 210 million units (15%). Regionally, Asia-Pacific dominated with 588 million units (42%), followed by North America with 380 million (27%), Europe with 336 million (24%), and Middle East & Africa with 98 million (7%). Competitive insights show Thermo Fisher and Merck leading with a combined 26% share. Coverage includes Serum Market Trends, Serum Market Analysis, Serum Market Forecast, and Serum Industry Report insights into investments, product development, and opportunities across biological research, skincare, and healthcare applications.

Serum Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1297.26 Million in 2026
Market Size Value By	USD 2552.44 Million by 2035
Growth Rate	CAGR of 7.81% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : FBS Bovine Serum Others By Application : Research Biological Products Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample